Lilly Announces Agreement To Acquire Loxo Oncology

Acquisition will broaden the scope of Lilly's oncology portfolio into precision medicines through the addition of a marketed therapy and a pipeline of highly selective potential medicines for patients with genomically defined cancers. Loxo Oncology's pi... Biopharmaceuticals, Oncology, Mergers & Acquisitions Eli Lilly, Loxo Oncology, Vitrakvi, larotrectinib
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news